Pritelivir clinical trials
Also written AIC316.
How each study uses pritelivir is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 9 Oct 2026 · HOVILPR · NDA 221154 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
5 studies that test it; most in 2010 (1)
| Year | Studies |
|---|---|
| 2010 | 1 |
| 2012 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2020 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 5 · Other 0
AiCuris Anti-infective Cures AG (5)
Studies
Open first, then newest update. How each study uses pritelivir is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised SubjectsCompletedPhase 3AiCuris Anti-infective Cures AGNCT03073967Written as Pritelivir
- Potential Influence of Esomeprazole on the Pharmacokinetics of PritelivirCompletedPhase 1AiCuris Anti-infective Cures AGNCT05513625Written as Pritelivir
- Safety and Efficacy Study for a New Antiviral Drug to Treat Genital Herpes Type 2CompletedPhase 2AiCuris Anti-infective Cures AGNCT01047540Written as AIC316
- Safety and Efficacy Comparator Trial of a New Drug Against Genital HerpesTerminatedPhase 2AiCuris Anti-infective Cures AGNCT01658826Written as AIC316
- Trial on Efficacy and Safety of Pritelivir Ointment for Treatment of Labial HerpesCompletedPhase 2AiCuris Anti-infective Cures AGNCT02871492Written as Pritelivir 5% w/w ointment
Codes
What other systems call pritelivir · ClinicalTrials.gg INT004439
- MeSH (NLM) C453221pritelivirConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 07HQ1TJ4JEPRITELIVIRConfirmed FDA, NLM, Wikidata
- Wikidata Q15410303pritelivirConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C136516PritelivirOne source FDA
- DrugBank DB11844One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C453221 | pritelivir | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 07HQ1TJ4JE | PRITELIVIR | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q15410303 | pritelivir | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C136516 | Pritelivir | One source FDA |
| DrugBank | DB11844 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.